AN-788: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 3: | Line 3: | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{short-articles-ni}} | {{short-articles-ni}} | ||
{{No image}} | |||
Latest revision as of 05:29, 10 February 2025
AN-788, also known as NSD-788, is an experimental medication which was originated by NeuroSearch and is under development by Aniona and Saniona for the treatment of major depressive disorder. It was also under development for anxiety disorders, but development for this indication was discontinued. The drug acts as a serotonin–dopamine reuptake inhibitor (SDRI). As of April 2016, it is in phase I clinical trials for major depressive disorder.
| This article is a stub. You can help WikiMD by registering to expand it. |
